Edesa Biotech Inc (EDSA)
4.632
+0.08
(+1.70%)
USD |
NASDAQ |
May 03, 16:00
4.53
-0.10
(-2.21%)
After-Hours: 20:00
Edesa Biotech Cash from Financing (Quarterly): 0.3057M for Dec. 31, 2023
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.3057M |
| September 30, 2023 | 0.4125M |
| June 30, 2023 | 0.7412M |
| March 31, 2023 | 0.7646M |
| December 31, 2022 | 2.912M |
| September 30, 2022 | -0.0003M |
| June 30, 2022 | 0.00 |
| March 31, 2022 | 10.40M |
| December 31, 2021 | 1.228M |
| September 30, 2021 | 0.221M |
| June 30, 2021 | 0.0159M |
| March 31, 2021 | 11.94M |
| December 31, 2020 | 1.995M |
| September 30, 2020 | 3.228M |
| June 30, 2020 | -0.0275M |
| March 31, 2020 | 3.847M |
| December 31, 2019 | 0.045M |
| March 31, 2019 | |
| December 31, 2018 | |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 8.772M |
| March 31, 2018 | |
| December 31, 2017 | |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| Date | Value |
|---|---|
| March 31, 2017 | |
| December 31, 2016 | |
| September 30, 2016 | 5.945M |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 1.368M |
| September 30, 2015 | 0.0781M |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.0287M |
| August 31, 2014 | 0.1065M |
| May 31, 2014 | 0.0151M |
| February 28, 2014 | 0.4891M |
| November 30, 2013 | 10.18M |
| August 31, 2013 | 6.738M |
| May 31, 2013 | 1.557M |
| February 28, 2013 | 0.078M |
| November 30, 2012 | 1.357M |
| August 31, 2012 | 0.0185M |
| May 31, 2012 | 0.0279M |
| February 29, 2012 | 0.001M |
| November 30, 2011 | 0.8297M |
| August 31, 2011 | 0.0083M |
| May 31, 2011 | 0.0995M |
| February 28, 2011 | 0.2354M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-0.0275M
Minimum
Jun 2020
11.94M
Maximum
Mar 2021
2.237M
Average
0.7412M
Median
Jun 2023
Cash from Financing (Quarterly) Benchmarks
| Acasti Pharma Inc | 0.00 |
| Aurinia Pharmaceuticals Inc | -5.577M |
| Lexaria Bioscience Corp | 3.453M |
| Xenon Pharmaceuticals Inc | 324.01M |
| ESSA Pharma Inc | 0.1967M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -1.406M |
| Free Cash Flow | -6.252M |
| Free Cash Flow Per Share (Quarterly) | -0.4497 |
| Free Cash Flow Yield | -45.03% |